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ABSTRACT: 
Aim of present work was to formulate and evaluate oral floating beads of Tramadol hydrochloride. Floating beads were fabricated 
using modified ionotropic gelation technique using various natural and synthetic polymers in different proportion. In the 
formulated batches BT1 to BT11 not have ability to extend drug release for 12 hours. In formulated batch BT 12 (Sodium alginate 
6%: Carbapol 940 1.2 %) show in vitro release for 12 hours (100.26 ± 0.66% ). It also has floating lag time and floating time 
immediate, and floating duration more than 12 hours. In kinetic model fitting it follows Korsemeyers Peppas equation. Also it was 
found stable after 6 months in accelerated stability study. From all the formulation of oral floating beads of Tramadol 
Hydrochloride; it was concluded that, among all different polymer ratio Sodium Alginate 6% and CaCl2 3% (2:1 ratio) gives best 
results. Among different polymers Carbapol 940 gives retarded drug release for 12 hours. The optimized batch was found to be 
stable after 6 Months in accelerated stability studies. 
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1. INTRODUCTION: 
Rapid GI transit can prevent complete drug release in 
the absorption zone and reduce the efficacy of the 
administered dose since the majority of drugs are 
absorbed in stomach or the upper part of small 
intestine. To overcome these limitations, several 
controlled oral drug delivery systems with prolonged 
gastric residence times have been reported recently 
such as: floating drug dosage systems (FDDS). 
Swelling or expanding systems, mucoadhesive 
systems, modified-shape systems, high-density 
systems and other delayed gastric emptying devices. 
Among these systems, FDDS have been most 
commonly used. FDDS have lower density than gastric 
fluids and thus remain buoyant in the stomach without 
affecting the gastric emptying rate for a prolonged 
period of time. While the system is floating in the 
gastric content, the drug is released slowly from the 
system at a desired rate. Materials used for FDDS 
include carbon dioxide gas-forming agents (carbonate 
or bicarbonate compounds) highly swellable 
hydrocolloids and light mineral oils. Multiple unit 
systems and hollow systems prepared by solvent 
evaporation methods have also been developed.
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Floating drug delivery systems (FDDS) are classified 
depending on the use of two formulation variables: (i) 
Effervescent system and (ii) Non effervescent system. 
Effervescent floating drug delivery systems are again 
classified into volatile liquid containing systems and 
gas-generating systems. In volatile liquid containing 
systems, the gastro retention time of a drug delivery 
system can be sustained by incorporating an inflatable 
chamber, which contains a liquid e.g. ether, 
cyclopentane, that gasifies at body temperature to 
cause the inflation of the chamber in the stomach. The 
device may also consist of a bioerodible plug made up 
of PVA, Polyethylene, etc., that gradually dissolves 
causing the inflatable chamber to release gas and 
collapse after a predetermined time to permit the 
spontaneous ejection of the inflatable systems from the 
stomach. In gas-generating systems, the buoyant 
delivery systems utilize effervescent reactions between 
carbonate / bicarbonate salts and citric / tartaric acid to 
liberate CO2, which gets entrapped in the jellified 
hydrocolloid layer of the systems thus decreasing its 
specific gravity and making it to float over time.  
Non-effervescent floating drug delivery systems are 
again classified into: 
(i) Colloidal Barrier systems contains  
(ii) Micro Porous Compartment Systems  
(iii) Alginate beads  
(iv) Hollow microspheres  
Alginate beads: Beads are small, solid and free 
flowing particulate carriers containing dispersed drug 
particles either in solution or crystalline form
2
. 
Spherical beads of approximately 2.5 mm in diameter 
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can be prepared by dropping a sodium alginate 
solution in to aqueous solutions of calcium chloride, 
causing precipitation of calcium alginate. The beads 
are then separated snap and frozen in liquid nitrogen, 
and freeze dried at -40°C for 24 h, leading to the 
formation of porous system, which can maintain a 
floating force over 12 h.
3
 
In multiple-unit particulate dosage forms (e.g. 
microspheres, gel beads) have the advantages that they 
pass uniformly through the GIT to avoid the vagaries 
of gastric emptying and provide an adjustable release, 
thereby, reducing the inter subject variability in 
absorption and risk of local irritation.
4
 
The beads are generally fabricated using modified 
ionotropic gelation technique. In this approach, an 
aqueous dispersion of negatively charged polymer 
together with a gas generating agent (CaCO3 or 
NaHCO3) was added drop-wise into acidic gelation 
medium consisting of divalent cations such as Ca2+. 
As the droplet dips into the acidic gelation medium, 
gas-generating agent effervesces, releasing CO2 which 
then is entrapped in the gel matrix making it lighter 
than stomach fluids and simultaneously Ca2+ present 
in gelation medium interacts with anionic groups on 
polymer molecule causing immediate formation of 
strong aggregation of pairs of helices, leading to strong 
bead shaped gel structures.
5
 
In the present study Tramadol Hydrochloride was 
used, it is a NSAID drug having suitable 
Pharmacokinetic criteria for formulation of sustains 
release dosage form. 
6-8 
2. MATERIAL AND METHOD: 
2.1 Material: 
Drug: Tramadol Hydrochloride (Yarrow Chem), 
Polymers: sodium alginate, pectin, ethyl cellulose, 
HPMC K100M, guar gum, carbapol 940. Excipients: 
Sodium bicarbonate, calcium chloride, glacial acetic 
acid. 
2.2 Method: 
Floating beads were fabricated using modified 
ionotropic gelation technique using various natural and 
synthetic polymers in different proportion. Firstly to 
the water sodium alginate was incorporated with 
constant stirring at 1000 rpm on magnetic stirrer for 
half hour. Then other polymers like pectin, HPMC 
K100 M,  Carbapol 940 etc  were added one by one 
after interval of  45 minutes. Then to this sodium 
bicarbonate was added and again it was stirred for 30 
minutes or until solution should be clear. Lastly drug 
was added and solution was stir for 1 hour.   
In another beaker 99ml of water was taken to then 3% 
CaCl2 was added in water and was stirred for 10 
minutes on magnetic stirrer at 500 rpm. Then to this 
solution of water and CaCl2, 1% glacial acetic acid was 
added it was again stir of 10 minute. 
Then the mixture of drug and polymer was filled in 10 
ml syringe. The needle used was 20 G number. this 
solution was then drop by drop added to water CaCl2 
and Glacial acetic acid solution with constant stirring 
at 400-450 rpm. Then beads were formed. These beads 
were filtered through whattman’s filter paper. Then 
these are air dried overnight to get constant weight. 
Mixture (sodium alginate + other polymers + gas 
forming agent + drug) 
   
Dropping in to CaCl2 + acetic acid solution 
  
 
             
 
Separation  
 
Air dried 
Figure 1: Schemes diagram of formulation of 
Floating Beads of Tramadol Hydrochloride
9
 
 
3. Evaluation of Oral Floating Beads:10-13 
3.1 Preformulation Studies: 
In the preformulation studies Bulk density, Tapped 
density, Compressibility index, Hausner’s ratio, Angle 
of repose, FTIR were performed.  
3.2 Morphological Study using SEM:  
Scanning electron microscopy (SEM): The surface 
topography of the (optimized) beads formulations were 
examined under a FEI-Philips XL-30 Analytical 
Electron microscope (VNIT NAGPUR). The sample 
was loaded on copper sample holder and sputter coated 
with platinum. 
3.3 Percentage Drug Entrapment Efficacy 
(%DEE): 
The yield of beads were determined by comparing the 
whole weight of beads formed against the combined 
weight of the copolymer and drug. 
                Mass of beads obtained 
% Practical yield = ------------------------------- X 100 
               Total wt of drug & polymer
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Table 1: Formulation of oral floating Beads of Tramadol beads (weights in %) 
Name of 
ingredients  
Formulation Code 
BT1 BT2 BT3 BT4 BT5 BT6 BT7 BT8 BT9 BT10 BT11 BT12 
Tramadol 
HCl (mg) 
100 100 100 100 100 100 100 100 100 100 100 100 
Sodium 
alginate 
6 6 6 6 6 6 6 6 6 6 6 6 
Pectin 3 - - - - 2 - - - - - - 
Ethyl 
cellethyl  
- 3 5 - - - - - - - - - 
Guar gum - - - - - - 0.7 - - - - - 
HPMC 
K100 M  
- - - 1.5 2 3 - - - - - - 
Carbapol 
940 
- - - - - - - 0.5 0.7 0.9 1 1.2 
Sodium 
bicarbonate 
3 3 3 3 3 3 3 3 3 3 3 3 
Calcium 
chloride 
3 3 3 3 3 3 3 3 3 3 3 3 
Glacial 
acetic acid 
1 1 1 1 1 1 1 1 1 1 1 1 
Distilled 
water  
99 99 99 99 99 99 99 99 99 99 99 99 
 
3.4 Drug Content Uniformity: 
Accurately weighed beads equivalent to 100 mg were 
suspended in 100 ml of 0.1 N Hydrochloric acid, it 
was shaked for 30 min  and kept for 24 hrs. Next day it 
was stirred for 5min and filtered. After suitable 
dissolution, the drug content in the filtrate was 
analyzed spectro photo metrically at using Shimadzu 
UV spectrophotometer at 271 nm. 
The drug content uniformity was calculated by- 
Percentage Drug Entrapment Efficiency  
= Actual drug content/ Theoretical drug content X 100 
                                                                     
3.5 Floating lag time In this parameter 100 mg of 
beads formulation were added into the 900 ml 
dissolution vessel containing 0.1N HCl at 37
0
C. It was 
the time the formulation took to emerge on surface of 
dissolution medium is referred as floating lag time.  
3.6 Floating duration In this parameter 100 mg of 
beads formulation was added into the 900 ml 
dissolution vessel containing 0.1N HCl at 37
0
C. The 
time for which the formulation remains constantly 
floating on surface of dissolution medium was referred 
as duration of floating. 
3.7 Filled capsules parameter:  
a. Capsule appearance: The prepared capsule was 
evaluated visually.  
b. Capsule lock length: The capsules lock length was 
determined using Vernier caliper. Six capsules from 
each batch of formulation were used and mean lock 
length value and stand.  
c. Weight variation: To study the weight variation, 20 
capsule of each formulation were weighed using an 
electronic digital balance. The average weight of each 
capsule was calculated and the percentage deviation in 
weight was calculated.  
3.8 In vitro dissolution study
 
An in vitro release 
study was carried out using dissolution test apparatus 
USP Type II (Paddle Method). Dissolution parameters 
used for the study are as given in table no.2. 
Table 2: Parameters used in Invitro dissolution 
study of oral floating beads: 
Dissolution medium  900 ml of Hydrochloric acid 
buffer solution of pH 1.2  
Temperature 37
0
C ± 0.2
0
C  
Speed of 
rotation(RPM) 
50  
Wavelength of drug 271 nm 
 
3.9 Drug Kinetic study:  
The release data obtained from various batches were 
studied with respect to effect of drug: polymer ratio. 
To analyze the mechanism of drug release from the 
formulation, the dissolution profile of optimized 
batches was fitted to zero-order, first-order, Higuchi, 
Hixson-Crowell, Korsemeyer and Peppas, models to 
ascertain the kinetic modeling of drug release.  
3.10 Statistical Analysis:  
In this study the Bonferroni method was applied to 
dissolution study to check there was significant 
difference or not 
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3.11 Stability testing: 
Stability studies were carried out as per ICH 
guidelines. During the stability studies, the product is 
exposed to normal conditions of temperature and 
humidity. The optimized were subjected for stability 
studies.  
4. RESULT AND DISCUSSION: 
4.1  Preformulation Studies:  
All the preformulation studies like bulk density , tap 
density, angle of repose etc, physical characterization 
of drug sample, Analytical characterization of drug 
sample were performed. 
 
Table 3: Preformulation testing (g= gram) 
Sr. 
No 
Formulatio
n Code 
Bulk density 
(gm/cm3) 
Tapped 
density (g/cm3) 
Compressibility 
Index (%) 
Hausner Ratio Angle of Repose 
(θ) 
1 BT1 0.54 ±0.21 0.62 ±0.29 11.96 ±0.17 1.14 ±0.17 26.57 ±0.33
0
 
2 BT2 0.62 ± 0.23 0.69 ±0.27 11.11 ±0.33 1.13 ±0.22 27.51 ±20
0
 
3 BT3 0.57 ±0.098 0.63 ±0.19 9.71 ±0.25 1.11 ±0.16 29.05 ±0.21
0
 
4 BT4 0.65 ± 0.13 0.71 ±0.17 9.68 ±0.29 1.11 ±0.20 28.52 ±0.26
0
 
5 BT5 0.54 ± 0.33 0.59 ±0.13 8.60 ±0.12 1.09 ±0.16 29.60 ±0.32
0
 
6 BT6 0.56 ±0.20 0.77 ±0.19 27.78 ±0.22 1.38 ±0.13 30.76 ±0.22
0
 
7 BT7 0.58 ±0.22 0.65 ±0.22 10.47 ±0.31 1.12 ±0.21 27.51 ± 0.19
0
 
8 BT8 0.63 ±0.11 0.70 ±0.15 11.25 ±0.18 1.13 ±0.13 29.38 ±0.28
0
 
9 BT9 0.63 ±0.15 0.74 ±0.25 15 ±0.19 1.18 ±0.19 29.89 ±0.17
0
 
10 BT10 0.64 ±0.99 0.72 ±0.27 11.54  ±0.17 1.13 ±0.099 27.22 ±0.13
0
 
11 BT11 0.58 ±0.19 0.66 ±0.34 11.63 ±0.22 1.13 ± 0.14 26.89 ±0.25
0
 
12 BT12 0.68 ±0.12 0.77 ±0.17 12.16 ±0.32 1.14 ±0.22 28.52 ±0.15
0
 
N=3 
The results of the bulk density and tapped density were 
mentioned in an above table. The bulk density and 
tapped density values were lies in between 0.54 ±0.21 
to 0.68 ±0.12 g/cm
3
 and 0.62 ±0.29 to 0.77 ±0.19 g/cm
3
 
i.e. less than 1.2, indicates good packing.  
The values of % compressibility, Hausner ratio and 
angle of repose were lies in between 8.60% ±0.12% to 
27.78% ±0.22%, 1.09 ±0.16 to 1.38 ±0.13 and 26.57 
±0.33
0
 to 30.76 ±0.33
0
 respectively indicates acceptable 
flow property and also good packing ability. 
4.2 FTIR Spectroscopy: 
IR spectra of pure Tramadol Hydrochloride and 
polymers viz. Sodium Alginate, Carbapol 940 etc were 
taken separately. Then to know if there is any 
interaction between drug and polymer, IR spectra of 
Tramadol Hydrochloride and other polymers were taken 
in combination.(fig no 2, 3, 4, 5) 
Interpretation: 
There was no drug interaction in drug and polymers 
since the peaks of pure drug and polymers retains in 
combination. 
 
 
Figure 2: IR of Tramadol HCl 
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Figure 3: IR of Sodium Alginate 
 
Figure 4: IR of Carbapol 940 
 
Figure 5: IR of Tramadol HCl + Sodium Alginate + Carbapol 940 
 
Table 4: Principle peaks and chemical groups present in IR spectrum of Tramadol HCl, Sodium Alginate and 
carbapol 940 
Sr 
no 
Functional 
groups in 
Tramadol HCl 
Peaks values 
(cm
-1
) in 
Tramadol HCl 
Peaks values 
(cm
-1
) in 
Sodium 
Alginate 
Peaks values 
(cm
-1
) in 
Carbapol 940 
Peaks values  (cm
-
1
) in Constitution 
Combination 
Interpretation  
1 -OH 3298 - - 3302.13 No Interaction 
2 =C-H 3008 - - 2931 No Interaction 
3 -C-H 2943.37 - - 2862.36 No Interaction 
4 -C-O - 1620 1716.06 1684 No Interaction 
5 -C=C 1789.94 1747.84 - 1700 No Interaction 
6 -COOH -  3700 -3000 
Broad peak 
3700 -3000 Broad 
peak 
No Interaction 
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4.3 Morphological Studies Using SEM: 
The morphology of optimized batch of bead was 
characterized by Scanning Electron Microscope 
(SEM). The surface topography of the (optimized) 
beads formulations were examined under a FEI-
Philips XL-30 Analytical Electron microscope (VNIT 
NAGPUR). The sample was loaded on copper sample 
holder and sputter coated with platinum. (fig no 6,7 ) 
 
 
Figure 6: SEM of Oral Floating Beads of 
Tramadol HCl (A) 
 
Figure 7: SEM of Oral Floating Beads of 
Tramadol HCL (B) 
4.4 Characterization of oral floating beads of 
Tramadol Hydrochloride: 
For the Characterization of oral floating beads of 
Tramadol Hydrochloride, Percentage Drug 
Entrapment Efficacy (%DEE), Drug content 
uniformity, Floating lag time, Floating duration etc 
tests were performed and the results were as follows:
 
Table 5: Various Characterizations of Oral Floating Beads of Tramadol HCl 
Formulation code %DEE Drug content Uniformity (%) Floating lag time (Sec) Floating Time (Hr) 
BT1 89 30 23 >12 
BT2 90 29 25 >12 
BT3 92 25 27 >12 
BT4 93 25 12 >12 
BT5 88 31 16 >12 
BT6 85 35 10 >12 
BT7 81 34 10 >12 
BT8 86 38 10 >12 
BT9 77 32 Immediate >12 
BT10 79 30 Immediate >12 
BT11 84 33 Immediate >12 
BT12 90 35 Immediate >12 
 
a) % Drug Entrapment Efficiency (%DEE): The 
yield of beads were determined by comparing the 
whole weight of beads formed against the 
combined weight of the polymer and drug and 
excipients. %DEE of formulated beads was found 
to be 77 to 93%. The optimized batch BT12 shows 
% DEE as 90% (as given in table 5) 
b) Drug Content Uniformity: All the prepared 
formulations show drug content uniformity in the 
range of 25-38 %. The optimized batch show drug 
content uniformity 35%.(as given in table 5) 
c) Floating Lag time : Floating lag time of all the 
prepared formulations was observed by visual 
examination. All the prepared formulations show 
Floating lag time from 27 seconds to immediate. 
And the optimized batch BT 12 show immediate 
floating after entering in 0.1 N HCl and show 
floating for more than 12 hrs. (as given in table 5) 
d) Floating Duration: All prepared formulation show 
floating duration more than 12 hours. (as given in 
table 5) 
4.5 Evaluation of Filled Capsule: 
 Physical Description 
 Colour : Yellow 
 Weight of empty capsule :65±3 mg 
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Table 6: Other Evaluation parameters of Floating Beads of Tramadol HCl 
Parameters BT1 BT2 BT3 BT4 BT5 BT6 BT7 BT8 BT9 BT 
10 
BT 
11 
BT 
12 
Capsule 
Lock 
Length 
15.6 15.6 15.6 15.6 15.6 15.6 15.6 15.6 15.6 15.6 15.6 15.6 
Weight 
Variation 
Passes  Passes Passes Passes Passes Passes Passes Passes Passes Passes Passes Passes 
 
Capsules of different formulations were subjected to 
various evaluation tests, such as capsule lock length, 
uniformity of weight, drug content. All batches showed 
uniform capsule lock length. The weight variation test 
was carried out as per official method and the per cent 
deviation of formulation was found to be within limit. 
4.6 Invito Dissolution Study for Oral Floating Beads 
of Tramadol HCl 
Drug release from beads, depends upon the extent of 
cross– linking, morphology, size and density of beads, 
physicochemical properties of the drug as well as the 
presence of adjuvants. In vitro release also depends 
upon pH, polarity and presence of enzymes in the 
dissolution media. 
 The formulated batch BT1(Sodium alginate 
6%:Pectin 3% ) gave in vitro release for 2 hours, 
batch BT2(Sodium alginate 6%: Ethyl cellulose 3% 
) gave in vitro release for 2 hours, batch 
BT4(Sodium alginate 6%:HPMC K100 M 1.5% ) 
gave in vitro release for 1 hours, batch BT5(Sodium 
alginate 6%:HPMC K 100M 2% ) gave in vitro 
release for 3 hours, batch BT6 (Sodium alginate 
6%:HPMC K100 M 3% ) gave in vitro release for 4 
hours, formulated batch BT7 (Sodium alginate 
6%:Guar gum 0.7 % ) gave in vitro release for 5 
hours, batch BT8 (Sodium alginate 6%:Carbapol 
940 0.5% ) gave in vitro release for 4 hours, batch 
BT9(Sodium alginate 6%: Carbapol 940 0.7 % ) 
gave in vitro release for 7 hours, batch BT10 
(Sodium alginate 6%: Carbapol 940 0.9 % ) gave in 
vitro release for 9 hours, batch BT11 (Sodium 
alginate 6%: Carbapol 940 1 % ) gave in vitro 
release for 10 hours. As all these batches did not 
show drug release for 12 hours they did not give 
gastro retentive drug release. In all these batch use 
of polymers like pectin, guar gum, ethyl cellulose, 
HPMC K100 M were used in different polymeric 
ratio but cross linking was not enough to retard the 
drug release.  
 In the formulated batch BT12 (Sodium alginate 6%: 
Carbapol 940 1.2 % ) gave in vitro release for 12 
hours. As it releases drug for 12 hours 
(100.26±0.66), and gave floating lag time 
immediate and floating duration more than 12 
hours. It can be because sodium alginate is gel 
formulating agent and swelling agent and Carbapol 
940 is emulsifying and gelling agent so combination 
of these two polymers gave release retarding beads 
with 90% drug entrapment efficiency. Also it 
follows all pre requisitions, on this basis this batch 
was optimized. Statistically it show significant 
difference from other batches. 
 
 
 
Figure 8: % Invitro drug release of batches BT1 to BT4 
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Figure 9: % Invitro drug release of batches BT5 to BT8 
 
Figure 10: % Invitro Drug release of batches BT9 to BT12 
 
In the present study various natural as well as synthetic 
polymers were used in the combination and in 
different ratio. But in the formulated batches BT1 to 
BT11 did not gave drug release for 12 hours. In 
formulated batch BT 12 (Sodium alginate 6% : 
Carbapol 940 1.2 %) show in vitro release for 12 hours 
(100.26 ± 0.66% ). It also gave floating lag time and 
floating time immediate, and floating duration more 
than 12 hours. Hence it show gastric retention it can be 
because sodium alginate is gel formulating agent and 
swelling agent and Carbapol 940 is emulsifying and 
gelling agent so combination of these two polymers 
formulates release retarding beads with 90% drug 
entrapment efficiency. In kinetic model fitting it 
follows Korsemeyers Peppas equation. Also it was 
found stable in 6 months of accelerated stability study. 
So batch BT 12 was optimized. 
4.7 Kinetic Studies: 
The release data obtained from various batches was 
studied with respect to effect of drug: polymer ratio, 
diluents ratio. Dissolution data of drug from prepared 
in situ gel at different time periods was plotted as 
cumulative % drug release v/s time. The dissolution 
data so obtained was fitted to various kinetic models 
like Zero Order, First order, Higuchi, Korsmeyer-
Peppas models. It was found that the optimized batch 
IB12 follow Korsmeyr-pappas model. 
The drug release kinetics from all the batches were 
calculated, which was illustrated as follows- 
Table 7: Kinetic study of Oral Floating Beads of Tramadol HCl 
Batch Zero order First order Matrix Peppas Hixon crowell Best model fit  
BT1 0.9685 0.9663 0.998 1 0.9969 Peppas 
BT2 0.9508 0.9888 9986 1 0.97 Peppas 
BT3 0.8437 0.9591 0.9846 0.9727 0.964 Matrix 
BT4 0.652 0.9799 0.9547 0.9939 0.9362 Peppas 
BT5 0.9091 0.9729 0.9959 0.996 0.9902 Peppas 
BT6 0.7764 0.9764 0.9685 0.9764 0.9368 Peppas 
BT7 0.7441 0.9758 0.9707 0.9976 0.967 Peppas 
BT8 0.8043 0.9879 0.978 0.9943 0.968 Peppas 
BT9 0.6599 0 0.9615 0.9901 0.9303 Peppas 
BT10 0.8613 0 0.9863 0.9608 0.8458 Matrix  
BT11 0.8529 0 0.9914 0.9776 0.8673 Matrix 
BT12 0.9389 0 0.9693 0.9797 0.8606 Peppas 
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4.8 Stastical Analysis: 
In this study the Bonferroni method was applied to 
dissolution study to check there was significant 
difference or non significant difference in release of 
drug in formulated formulations. The optimized batch 
show significant difference from all other formulated 
batches. The description is given in table no 8.
 
Table 8: Statistical Analysis of Dissolution parameters of Floating Beads of Tramadol HCl: 
Sr. No Between batches t-test P-value (<0.05) Significance 
1 BT12 vs BT 1 2.840 P < 0.05 S 
2 BT12 vs BT 2 2.906 P < 0.05 S 
3 BT12 vs BT 3 3.704 P < 0.05 S 
4 BT12 vs BT 5 2.781 P < 0.05 S 
5 BT12 vs BT 6 3.874 P < 0.05 S 
6 BT12 vs BT 7 4.784 P < 0.05 S 
7 BT12 vs BT 8 3.839 P < 0.05 S 
8 BT12 vs BT 9 6.799 P < 0.05 S 
9 BT12 vs BT 10 7.286 P < 0.05 S 
10 BT12 vs BT 11 8.789 P < 0.05 S 
 
4.9 Stability Study: 
Stability studies were carried out as per ICH 
guidelines. The optimized formulation BT12 was 
exposed to accelerated stability conditions as 
40°C±2°C 75%RH±5% RH for the period of 6 months. 
In between the stability studies the formulation was 
removed at 3 month and 6 month to check all the 
evaluation tests as floating lag time, floating time, 
Floating duration, Dissolution studies etc. During the 
stability studies, the product was exposed to normal 
conditions of temperature and humidity. The optimized 
batch was found to be stable for all the evaluation tests 
in this time period of stability testing. 
 
Table 9: Various characteristics of oral floating Beads of Tramadol HCl during stability study 
Stability Duration %DEE Drug content Uniformity (%) Floating lag time (Sec) Floating Time (Hr) 
Zero month  90 35 Immediate > 12 
After 3 Month 90 35 Immediate > 12 
After 6 Month 90 35 Immediate > 12 
 
 
Figure 11: % Drug release of  Oral Floating Beads of Tramadol  HCl  during stability study. 
Table 10: Kinetic study of Oral Floating Beads of Tramadol HCl during stability study 
Time / Model Zero order First 
order 
Matrix Peppas Hixon crowell Best Model fit 
ZERO MONTH 0.9389 0 0.9693 0.9797 0.8606 Peppas 
3 MONTH 0.9456 0.8483 0.9715 0.9780 0.9453 Peppas 
6 MONTH 0.9518 0.8853 0.9732 0.9766 0.9564 Peppas 
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5. SUMMARY: 
In the present study various natural as well as synthetic 
polymers were used in the combination and in different 
ratio. Batch BT 12 (Sodium alginate 6% : Carbapol 
940 1.2 %) show in vitro release for 12 hours (100.26 ± 
0.66% ). It also gave floating lag time and floating time 
immediate and floating duration more than 12 hr with 
90% drug entrapment efficiency. In kinetic model 
fitting it follows Korsemeyers Peppas equation. Also it 
was found stable in 6 months of accelerated stability 
study.  
6. CONCLUSION: 
Sustained release floating beads of Tramadol 
Hydrochloride were successfully prepared by modified 
ionotropic gelation technique which is a very simple 
technique. 
From all the formulation and evaluation studies of oral 
floating beads of Tramadol Hydrochloride it was 
concluded that: 
 Among all different polymer ratio Sodium Alginate 
6% and CaCl2 3% (2:1 ratio) gives formulation of 
beads.  
 Among different polymers Carbapol 940 gives 
retarded release for 12 hours . 
 There was increase in residence time of drug in 
stomach also there was reduction of dosing 
frequency also the drug show safety profile.
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